TFS by compound
TFS records split by compound, with the index-wide comparison for the same compound beside each one. 18 compounds, 188 records. Cells below n=3 print their raw values instead of a median.
| Compound | Class | Reports | TFS median % | Index median % | Δ (pp) | Spec | Pass % |
|---|---|---|---|---|---|---|---|
| BPC-157 | Tissue-repair | 31 | 99.57 | 99.16 | +0.41 | 98.0 | 100 |
| CJC-1295 with DAC | Growth-hormone | 28 | 98.86 | 98.95 | -0.09 | 97.5 | 100 |
| Tirzepatide | Incretin | 19 | 98.73 | 98.55 | +0.18 | 97.0 | 89 |
| Semaglutide | Incretin | 15 | 98.38 | 98.89 | -0.51 | 97.0 | 100 |
| Retatrutide | Incretin | 14 | 98.68 | 98.37 | +0.31 | 96.5 | 100 |
| Selank | Neuroactive | 13 | 99.87 | 99.59 | +0.28 | 99.0 | 100 |
| Cagrilintide | Incretin | 13 | 99.34 | 98.69 | +0.66 | 96.5 | 100 |
| TB-500 | Tissue-repair | 11 | 99.72 | 99.53 | +0.19 | 98.5 | 100 |
| CJC-1295 (no DAC) | Growth-hormone | 10 | 98.94 | 99.09 | -0.15 | 98.0 | 100 |
| Kisspeptin-10 | Melanocortin-receptor | 9 | 99.10 | 99.28 | -0.18 | 98.5 | 100 |
| MOTS-c | Metabolic | 6 n=6 | 99.93 | 99.13 | +0.80 | 98.0 | 100 |
| SS-31 (Elamipretide) | Metabolic | 5 n=5 | 99.71 | 99.53 | +0.17 | 98.5 | 100 |
| Epitalon | Short | 4 n=4 | 99.93 | 99.56 | +0.37 | 99.0 | 100 |
| 5-Amino-1MQ | Non-peptide | 4 n=4 | 99.82 | 99.45 | +0.36 | 98.0 | 100 |
| MK-677 (Ibutamoren mesylate) | Non-peptide | 3 n=3 | 99.14 | 99.49 | -0.35 | 98.5 | 100 |
| L-Carnosine | Short | 1 n=1 | n<3 | 99.58 | — | 99.0 | 100 |
| Humanin (HNG) | Metabolic | 1 n=1 | n<3 | 99.12 | — | 97.5 | 100 |
| NAD+ | Non-peptide | 1 n=1 | n<3 | 99.28 | — | 97.0 | 100 |
Which of these lines TFS actually stocks
Coverage here reflects what has been submitted to the index, not what is on the catalogue. Thermo Fisher Scientific (China) Co., Ltd. lists considerably more than the 18 compounds above. Of those 18, 12 have been seen arriving from a domestic warehouse rather than as a cross-border consignment — that is the whole of what the index can say about which lines are held in regional stock, and it is a record of what was submitted, not a stock position. The catalogue and the current stock position are on the supplier's own site.